These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2871932)

  • 21. [Drug iatrogenesis in cardiology].
    Cunescu V; Pârvu V
    Med Interna (Bucur); 1971 Jan; 23(1):15-26. PubMed ID: 4929624
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].
    Baumgart P
    MMW Fortschr Med; 2006 Mar; 148(11):57, 59-60. PubMed ID: 16612965
    [No Abstract]   [Full Text] [Related]  

  • 23. [Arterial hypertension and cardiac arrhythmias].
    Vester EG
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lifestyle modifications to prevent and control hypertension. 4. Recommendations on physical exercise training. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Cléroux J; Feldman RD; Petrella RJ
    CMAJ; 1999 May; 160(9 Suppl):S21-8. PubMed ID: 10333850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of hypertension and coronary disease].
    Hermann B
    Orv Hetil; 1988 Jan; 129(1):50. PubMed ID: 2895444
    [No Abstract]   [Full Text] [Related]  

  • 26. [Anesthesia in patients with concomitant cardiovascular diseases].
    van Ackern K
    Anasth Intensivther Notfallmed; 1982 Sep; 17(5):258-63. PubMed ID: 6128941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiology of the hypertensive heart].
    Middeke M
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S253-6. PubMed ID: 19085801
    [No Abstract]   [Full Text] [Related]  

  • 30. Beyond blood pressure control. Effect of antihypertensive therapy on cardiovascular risk factors.
    Maxwell MH
    Am J Hypertens; 1988 Oct; 1(4 Pt 2):366S-371S. PubMed ID: 3056446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiac complications in hypertension].
    Slany J
    Wien Klin Wochenschr; 1972 May; 84(18):286-8. PubMed ID: 4554072
    [No Abstract]   [Full Text] [Related]  

  • 32. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
    Gulliford MC; Charlton J; Latinovic R
    J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Some cardiological problems in high mountains. Correlation with humans in flight].
    Gemelli A
    Minerva Med; 1980 Jul; 71(28):1985-9. PubMed ID: 6105636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease.
    Vale MJ; Jelinek MV; Best JD; Dart AM; Grigg LE; Hare DL; Ho BP; Newman RW; McNeil JJ;
    Arch Intern Med; 2003 Dec 8-22; 163(22):2775-83. PubMed ID: 14662633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesterol and coronary heart disease. The importance of patient-specific attributable risk.
    Malenka DJ; Baron JA
    Arch Intern Med; 1988 Oct; 148(10):2247-52. PubMed ID: 3178382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of stress and the sympathetic nervous system in hypertension and ischemic heart disease: advantages of therapy with beta-receptor blockers.
    DeQuattro V; Hamad R
    Clin Exp Hypertens A; 1985; 7(7):907-32. PubMed ID: 2864150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart disease and the law.
    Bucklin R
    South Med J; 1972 Apr; 65(4):496-8. PubMed ID: 5028410
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiac risk factor management.
    Beard TC
    Med J Aust; 1992 Feb; 156(4):295-6. PubMed ID: 1738348
    [No Abstract]   [Full Text] [Related]  

  • 39. Summary of research on the relationship of exercise to heart disease.
    MONTOYE HJ
    J Sports Med Phys Fitness; 1962 Mar; 2():35-43. PubMed ID: 14475580
    [No Abstract]   [Full Text] [Related]  

  • 40. [The heart and over-exertion].
    HOCHREIN M; SCHLEICHER I
    Med Klin; 1958 Jan; 53(2):41-7 contd. PubMed ID: 13516323
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.